(2006). Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure. Ann Pharmacother. http://doi.org/10.1345/aph.1G642.
(2007). Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens. http://doi.org/10.1097/HJH.0b013e328010520a.
(2014). Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-014-0455-6.
(2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z.
(2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3792.
(2016). Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3956.
(2016). Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13090.
(2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825.
(2016). High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther. http://doi.org/10.1111/apt.13583.
(2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816.